April 18, 2023
Bilge Ozaydin is the Director of the Strain Discovery and Development group at Pivot Bio. The QB3-Berkeley Professionals in Residence program will be joined by Ozaydin on Friday, May 5th.…
January 11, 2023
Miki Yamamoto, PhD, is the vice president and head of regulatory affairs at Arrivent Biopharma. Yamamoto is joining the QB3-Berkeley Professionals in Residence (PIR) program on February 9th 2023. UC…
November 15, 2022
Katja Brose, PhD, is a science program officer at the Chan Zuckerberg Initiative (CZI). Brose is joining the QB3-Berkeley Professionals in Residence (PIR) program on January 26th, 2023. UC Berkeley…
April 26, 2022
Seth Lieblich, PhD, is a principal at venture capital firm 8VC focusing on life sciences technologies. He joins the QB3-Berkeley Professional in Residence program on May 6th. Lieblich spoke to…
March 29, 2022
Timothy Day, PhD and UC Berkeley alumnus, is the co-founder and chief scientific officer (CSO) of DNALite Therapeutics. Day will be QB3-Berkeley’s Professional in Residence on April 5, 2022. In…
February 03, 2022
Christine Ring, PhD, JD, is the secretary of Nurix and the company’s general counsel. Ring is joining the QB3-Berkeley Professionals in Residence (PIR) program on Friday, Feburary 11th for two…
January 05, 2022
Elise Kikis, PhD, is a professor of biology and chair of the biology department at the University of the South (Sewanee). Kikis is joining the QB3-Berkeley Professionals in Residence (PIR)…
December 07, 2021
Erin Dueber, Ph.D., a Senior Principal Scientist in the Early Discovery Biochemistry Department at Genentech, spoke with graduate student Samvardhini Sridharan about her science career and how being unafraid to try things played a fundamental role along the way.